Compare MGYR & LNSR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | MGYR | LNSR |
|---|---|---|
| Founded | 1922 | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Savings Institutions | Medical Electronics |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 123.3M | 106.6M |
| IPO Year | 2021 | 2005 |
| Metric | MGYR | LNSR |
|---|---|---|
| Price | $19.39 | $7.05 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $10.00 |
| AVG Volume (30 Days) | 1.5K | ★ 89.5K |
| Earning Date | 04-23-2026 | 05-11-2026 |
| Dividend Yield | ★ 2.30% | N/A |
| EPS Growth | ★ 26.83 | N/A |
| EPS | ★ 1.47 | 0.61 |
| Revenue | N/A | ★ $58,435,000.00 |
| Revenue This Year | N/A | $10.06 |
| Revenue Next Year | N/A | $41.48 |
| P/E Ratio | $13.48 | ★ $11.62 |
| Revenue Growth | N/A | ★ 9.24 |
| 52 Week Low | $16.03 | $4.95 |
| 52 Week High | $20.00 | $12.94 |
| Indicator | MGYR | LNSR |
|---|---|---|
| Relative Strength Index (RSI) | 57.28 | 38.71 |
| Support Level | $16.95 | $5.17 |
| Resistance Level | $19.89 | $8.73 |
| Average True Range (ATR) | 0.39 | 0.36 |
| MACD | -0.03 | -0.26 |
| Stochastic Oscillator | 98.72 | 4.37 |
Magyar Bancorp Inc is an independent, community financial services provider offering traditional banking services to individual, business, and government customers. The Company attracts retail deposits through its main office in New Brunswick, New Jersey, and branch offices in Middlesex and Somerset Counties, and invests those funds mainly in commercial and residential real estate loans, commercial business loans, SBA loans, home equity loans and lines of credit, construction and land loans, and investment securities. Revenues are derived mainly from interest on loans and securities and from fees and service charges, with lending relationships focused on small to mid-sized businesses and individual consumers in central and northern New Jersey.
LENSAR Inc is a commercial-stage medical device company focused on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts. The company Laser System incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency, and reproducibility by providing imaging, simplified procedure planning, efficient design, and precision. Its product portfolio consists of the LENSAR Laser System with Streamline IV and IntelliAxis and its associated consumable components. Geographically, the company generates the majority of its revenue from the United States, followed by Europe, Asia (excluding South Korea), South Korea, and Other.